UNITED GUARDIAN INC
United-Guardian, Inc. (NASDAQ: UG) operates through its Guardian Laboratories division as a specialty manufacturer of cosmetic, personal care, and sexual wellness ingredients alongside a portfolio of healthcare products including pharmaceuticals and medical lubricants. The company maintains its principal facility in… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What UNITED GUARDIAN INC does
In the company’s own words
United-Guardian, Inc. (NASDAQ: UG) operates through its Guardian Laboratories division as a specialty manufacturer of cosmetic, personal care, and sexual wellness ingredients alongside a portfolio of healthcare products including pharmaceuticals and medical lubricants. The company maintains its principal facility in Hauppauge, New York, a 50,000 square foot property encompassing manufacturing, warehouse, research and development, and office space.
The company's product portfolio spans four distinct categories. Cosmetic ingredients, representing 29 percent of sales, include the Lubrajel line of multifunctional hydrogel formulations designed for sensory enhancement, lubrication, hydration, and texture in personal care products. Medical lubricants account for 20 percent of revenue and serve applications in catheters, surgical instruments, and oral care products. Pharmaceutical products comprise 51 percent of sales, anchored by Renacidin, an FDA-approved prescription drug for preventing and dissolving calcifications in urethral catheters, and Clorpactin, a chlorine-based topical antimicrobial. The company also develops sexual wellness ingredients through its newly launched Natrajel line, though these products generated no sales during 2025.
United-Guardian distributes cosmetic ingredients globally through five distributors, with Ashland Specialty Ingredients serving as the largest partner. Pharmaceutical products reach market through three national full-line drug wholesalers, while medical lubricants are sold directly to manufacturers and contract manufacturers of finished medical products. The company entered into a distribution agreement with Brenntag Specialties in January 2026 to expand sexual wellness and Lubrajel product distribution across North America and France.
The company employs 25 people and maintains ISO 9001:2015 certification and EFfCI Good Manufacturing Practices certification for cosmetic ingredients. Approximately 77 percent of sales derive from domestic sources, with foreign sales concentrated in medical lubricants and cosmetic ingredients distributed through international partners. The company's website is www.u-g.com, with a dedicated pharmaceutical product site at www.renacidin.com. United-Guardian was founded in 1942 and has maintained continuous ISO compliance since 1998.
Company details
- Sector
- Consumer Staples
- Industry
- Personal Care
- Headquarters
- HAUPPAUGE, NY
- Fiscal year end
- December
- CIK
- 101295
- SIC
- 2844
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns UNITED GUARDIAN INC — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · UNITED GUARDIAN INC’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do UNITED GUARDIAN INC and its peers compare on margins and cash generation over ten years?”
- “Where did five years of UNITED GUARDIAN INC's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in UNITED GUARDIAN INC's last four quarterly filings that the numbers alone won't show?”
